Virus News and Research

Latest Virus News and Research

Research roundup: Recession's big impact on men's insurance coverage

Researchers examined three sets of surveillance data and found that of the estimated 1.2 million persons in the United States living with the human immunodeficiency virus, 942,000 persons were aware of their infection. More than three-quarters of those were "linked to care" and among HIV-infected adults in care, "45 percent received prevention counseling, and 89 percent were prescribed antiretroviral therapy."

3 Dec 2011

On World AIDS Day, Obama announces plan to redirect $50 million to fight AIDS

President Barack Obama told advocates, patients and other stakeholders that his administration will do more to get antiretroviral drugs to people infected with HIV -; in the United States and in low-income countries around the world.

3 Dec 2011

Bristol-Myers Squibb and Tibotec partner to evaluate daclatasvir-TMC435 combination for HCV

Bristol-Myers Squibb Company announced today that it has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals to evaluate the utility of daclatasvir (BMS-790052), Bristol-Myers Squibb's investigational NS5A replication complex inhibitor, in combination with Tibotec Pharmaceuticals' investigational NS3 protease inhibitor, TMC435, for the treatment of chronic hepatitis C virus (HCV).

3 Dec 2011

Baby boomers more likely to develop HCV

Experts at Montefiore Medical Center urge the general public to be tested for the Hepatitis C virus, especially baby boomers, adults born between 1946-1964, who could be most at risk for this disease. Baby boomers are more likely to have been exposed to dangerous risk factors decades ago, such as sharing a drug needle, being tattooed or pierced with unsterilized tools or receiving a tainted blood transfusion.

2 Dec 2011

Bristol-Myers Squibb, Tibotec partner for TMC435 Phase II combination study in HCV

Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that its development partner, Tibotec Pharmaceuticals, has entered into an agreement with Bristol-Myers Squibb Company.

2 Dec 2011

Treatments for lymphoma with no side effects

Larry Conrad went in for his annual physical on his 50th birthday. During his exam, his doctor found swollen lymph nodes in his armpits and groin. Conrad had a cough and said he'd lost weight because he 'felt full all the time'. His doctor ordered a series of tests, and Conrad was diagnosed with Non-Hodgkin's lymphoma, the most common type.

2 Dec 2011

Longer looks: Life of a Medicare demo project; Broken hearts; AIDS funding

Today's Medicare demonstration project might determine how physicians interact with the program tomorrow, so naturally such projects generate a lot of buzz in the health care community. Lately, some of that buzz has been about how demos might provide part of the solution for Medicare's payment problems.

2 Dec 2011

Obama renews U.S. commitment to ending AIDS in World AIDS Day speech

President Barack Obama on Thursday renewed the U.S. commitment to ending HIV/AIDS in a speech marking World AIDS Day, and was joined by former presidents Bill Clinton, who participated by video, and George W. Bush, who spoke from Tanzania with that country's President, Jakaya Kikwete, the Independent reports.

2 Dec 2011

NAPWA advocates for fighting a three-fronted war against HIV/AIDS

"NAPWA, the largest and oldest advocacy group for people living with HIV/AIDS, advocates for fighting a three-fronted war against HIV/AIDS.

2 Dec 2011

Uncertainty about HIV pushes young Malawians to start families

People in Malawi who are uncertain about their HIV status are more eager to start families than those who are certain of their HIV status, according to researchers.

2 Dec 2011

Viewpoints: Bush, Bono and others reflect on World AIDS Day; Coburn and Burr on Medicare savings

On this Dec. 1, World AIDS Day, the promise of progress against the disease has never been more vivid -; or more fragile. ... In lean budget times, the U.S. and the developing world must prioritize. But there can be no higher priority than saving lives. And there is no better way to save lives than to support and expand effective, proven programs such as Pepfar.

2 Dec 2011

World AIDS Day marks progress, but much work remains

News reports detail emerging strategies to prevent infection, but also examine lagging treatments and the populations that continue to have the highest incidence rates.

2 Dec 2011

Two studies uncover limitations in screening for hepatocellular carcinoma

Two studies available in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, have uncovered limitations in screening for primary liver cancer, also known as hepatocellular carcinoma.

2 Dec 2011

Cheaper test as effective as a more sophisticated test in guiding anti-retroviral drug treatment

A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found - a discovery that could be particularly important in rural Africa.

2 Dec 2011

EGCG may prevent HCV reinfection after liver transplantation

German researchers have determined that epigallocatechin-3-gallate (EGCG)—a flavonoid found in green tea—inhibits the hepatitis C virus (HCV) from entering liver cells.

1 Dec 2011

Enrollment complete in Ceregene's CERE-120 Phase 2b trial for Parkinson's

Ceregene, Inc. reported today that it has completed enrollment in its Phase 2b trial of CERE-120, a gene therapy product expressing the neurturin (NRTN) gene for the treatment of Parkinson's disease.

1 Dec 2011

First Edition: December 1, 2011

In today's headlines, Republicans in Congress advance plan to charge wealthy beneficiaries more for Medicare in order to cover the costs of the proposaed payroll tax extension.

1 Dec 2011

South Africa 'witnessing first steps of AIDS-free generation'

In this Business Day opinion piece, Donald Gips, the U.S. ambassador to South Africa, examines progress made in the country's fight against HIV/AIDS, writing that, through the coordination of governments, civil society, nongovernmental organizations (NGOs), educational institutions, and researchers from around the world, "we now have the tools that allow us for the first time to set the goal of achieving an AIDS-free generation -- when virtually no children are born with the virus; we have effective and comprehensive education and prevention strategies that help to reduce risk; and those who are infected with HIV have access to treatment that helps prevent them from developing AIDS and transmitting the virus."

1 Dec 2011

Inadequate mask and respirator use put health care workers at risk of 2009 H1N1 infection

Inadequate use of masks or respirators put health care workers at risk of 2009 H1N1 infection during the earliest stages of the 2009 pandemic in the U.S., according to a study published in the December issue of Infection Control and Hospital Epidemiology, the journal of the Society of Healthcare Epidemiology of America.

1 Dec 2011

First study to investigate risk factors for CCSVI in patients without neurological disease

The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable similarity between this condition and possible or confirmed risk factors for multiple sclerosis.

1 Dec 2011